Question 1

What is Oruka Therapeutics, Inc.'s increase decrease in other accounts payable?

Accepted Answer

Oruka Therapeutics, Inc. (ORKA) reported increase decrease in other accounts payable of -$493K in Q1 2026.

Question 2

How has Oruka Therapeutics, Inc.'s increase decrease in other accounts payable changed year-over-year?

Accepted Answer

Oruka Therapeutics, Inc.'s increase decrease in other accounts payable decreased by 694.0% year-over-year, from $83K to -$493K.

Question 3

What does increase decrease in other accounts payable mean?

Accepted Answer

Represents the net change in miscellaneous short-term obligations owed to suppliers or service providers not classified under primary accounts payable. This metric helps investors track fluctuations in working capital requirements and short-term liquidity management.

Line item	Three Months Ended March 31, 2026	Three Months Ended March 31, 2025
Changes in operating assets and liabilities:
Prepaid expenses and other current assets	461	(148)
Other non-current assets	—	(60)
Accounts payable	(493)	83
Accrued expenses and other current liabilities	(1,304)	2,317
Operating lease liability	(125)	(21)
Related party accounts payable and other current liabilities	2,995	(5,205)
Net cash used in operating activities	(23,578)	(20,869)

Increase Decrease In Other Accounts Payable at other companies

Other financials

Income statement

Balance sheet

Cash flow

Valuation

Returns & leverage

Where this comes from

FAQ

Ask your AI about Oruka Therapeutics, Inc.'s increase decrease in other accounts payable.

Oruka Therapeutics, Inc. ORKA Increase Decrease In Other Accounts Payable